Skip to main content
. 2010 Jun 1;13(Suppl 1):S5. doi: 10.1186/1758-2652-13-S1-S5

Figure 1.

Figure 1

Laboratory (LCM) versus clinical (CDM) monitoring in the DART study Laboratory (LCM) versus clinical (CDM) monitoring in the DART study Source: Mugyenyi P, et al: Impact of routine laboratory monitoring over 5 years after antiretroviral therapy (ART) initiation on clinical disease progression of HIV-infected African adults: the DART Trial final results. 5th IAS Conference on Pathogenesis, Treatment and Prevention. TUSS103. [15]